SYNM

SYNM Full Name

synemin, intermediate filament protein

SYNM Introduction

SYNM, commonly known as synemin, is a multifunctional intermediate filament (IF) protein encoded by the SYNM protein-coding gene in humans. As a unique member of the intermediate filament cytoskeletal protein family, it differs from conventional IF proteins by combining structural cytoskeletal functions with critical signaling regulatory roles. Widely conserved across vertebrate species, synemin is primarily recognized for maintaining cellular mechanical stability, while emerging research has uncovered its indispensable involvement in cell signal transduction, tissue development, and disease pathogenesis.Consistent with the typical structural characteristics of intermediate filament proteins, synemin features a conserved tripartite architecture consisting of a central α-helical rod domain, a variable N-terminal head domain, and a flexible C-terminal tail domain. The central rod domain mediates homo- and heteropolymerization with other IF proteins, which is essential for filament assembly and cytoskeleton network formation. Distinct from most canonical IF proteins, SYNM undergoes alternative splicing, generating two major functional isoforms: α-synemin and β-synemin. These two isoforms differ in the length of their C-terminal tails, leading to divergent binding capabilities and tissue-specific functions. The extended tail region of α-synemin enables broader interactions with signaling molecules and cytoskeletal crosslinkers, while the shorter β-synemin predominantly undertakes structural support roles. Structurally unique, SYNM also contains specific binding motifs that allow it to act as an A-kinase anchoring protein (AKAP), a feature rare among intermediate filament family members.

Figure1.Schematic illustration of SYNM (synemin) function and molecular mechanism in cytoskeleton regulation.

Physiological Functions: From Mechanosupport to Signaling
At its core, synemin is a stress-response protein. In striated muscle, it forms a lateral "cross-bridge" between Z-discs and the sarcolemma, ensuring myofibrillar alignment and force transmission during contraction. It also plays a crucial role in maintaining nuclear positioning and mitochondrial distribution within myofibers. Beyond mechanics, synemin serves as a signaling hub; its ability to recruit AKAPs anchors PKA near the cytoskeleton, modulating phosphorylation events that regulate muscle metabolism and contraction strength. In the central nervous system, synemin (in astrocytes) supports the glial scaffold, and its upregulation has been observed in reactive gliosis following injury. Intriguingly, recent studies have identified synemin as a mechanosensor—its phosphorylation state changes in response to cyclic stretch, suggesting it actively participates in mechano-transduction pathways that inform the cell about its physical environment.

Association of SYNM Mutations with Human Diseases
Genetic variations and loss-of-function mutations in the SYNM gene are closely associated with human myopathic diseases, mainly cardiac and skeletal muscle disorders. Multiple clinical studies have confirmed that SYNM pathogenic variants are a causative factor for dilated cardiomyopathy, a common heart disease characterized by ventricular dilation and reduced cardiac contractility. In addition, SYNM mutations have been identified in rare cases of ulnar-mammary-like syndrome accompanied by left ventricular tachycardia, revealing its link with cardiac electrical conduction abnormalities. At the cellular level, SYNM deficiency or mutation disrupts the IF network integrity, impairs mechanosignaling transduction, and triggers myocyte dysfunction and injury. Animal model studies further verify that SYNM knockout mice develop spontaneous cardiac and skeletal myopathies, recapitulating human disease phenotypes. Currently, SYNM is recognized as a novel candidate gene for unexplained inherited myopathies, providing new targets for clinical genetic diagnosis and disease mechanism research.

Alternate Names for SYNM

SYNM; synemin, intermediate filament protein; desmuslin , DMN; synemin; KIAA0353; SYN; synemin alpha; synemin beta; Desmuslin; DMN; KIAA0353; SYN; Synemin alpha; synemin; Synemin beta; Synemin, intermediate filament protein; desmuslin; DMN;